Lv3
318 积分 2023-09-11 加入
Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis
1天前
已完结
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
1天前
已完结
Taking CAR T cells up a synthetic Notch
3天前
已完结
Synthetic cytokine circuits that drive T cells into immune-excluded tumors
3天前
已完结
TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH
4天前
已关闭
Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions
5天前
已完结
Relaxin in hepatic fibrosis: What is known and where to head?
5天前
已完结
A relaxin-based nanotherapy for liver fibrosis
5天前
已完结
World-first therapy using donor cells sends autoimmune diseases into remission
9天前
已完结
Targeting immune–fibroblast cell communication in heart failure
9天前
已完结
皖公网安备34019202002308
